Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...

Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...

A large, decades-long study suggests that signs of ADHD in childhood may have consequences that extend well beyond school and ...

If ADHD goes undiagnosed, it can harm self-esteem and mental health.

Though different people experience attention deficit hyperactivity disorder (ADHD) in different ways, it is something that can significantly disrupt a person's life. Whether in the classroom, ...

Difficulty focusing isn’t always ADHD. Attention problems can stem from sleep, stress, mental health, or medical factors.

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...

For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder (ADHD), centanafadine, setting up a decision by 24th July.